According to the Wegovy prescribing information (revised 06/2026), Wegovy injection is supplied as single-dose pens at 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg and 7.2 mg (Wegovy HD), as single-dose syringes with integrated needles, and as a single-patient-use FlexTouch pen containing 9.6 mg/3 mL that delivers four fixed weekly doses of 2.4 mg
Published 2019 Dec 2
Consequently, the extension phase of both trials was discontinued
Diabetes (2018) 67(11):215766
5-Amino-1MQ (5-Amino-1-Methylquinolinium) as distributed by Peptides Lab UK is not intended for, and must not be used for, human consumption, medical treatment, self-administration, veterinary applications, or any use outside of a controlled laboratory environment